Will the Art World Sack the Sacklers?

A branch of the Sackler family has publicly distanced itself from OxyContin profits as the clan and its company, Purdue Pharma, come under fire for the drug’s role in sparking the opioid crisis. But court documents suggest Arthur Sackler’s heirs have benefited at least indirectly from Oxy sales.

In 1997, as the blockbuster painkiller was taking off, the Purdue companies paid out $20 million to Arthur Sackler’s estate.

His heirs insist they have not benefited from Oxy profits, and have secured corrections in media outlets who’ve suggested as much. Meanwhile, pressure is mounting on elite art institutions receiving Sackler philanthropy to cut ties with the family.

The Atlantic via ProPublica

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top